A media release issued yesterday by Progenics Pharmaceuticals states that the investigational imaging agent 18F-DCFPyL changed physician behavior in the management of biochemically recurrent prostate cancer in > 65 percent of patients. … READ MORE …
Filed under: Uncategorized | Tagged: 18F-DCFPyL, biochemical, change, CT, imaging, Management, PET, recurrence, scan | Leave a comment »
Sometimes it is a good idea to take a step back from the details of what is going on in any particular medical field and take a look at the “big picture”. So that’s what your sitemaster is going to try to do today. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: advance, change, progress, revolution | 14 Comments »
One of our regular correspondents (who lives in England) was recently told something rather interesting by the Consultant Urologist he sees in the UK. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: change, future, Management, past, progress, Treatment | 4 Comments »
“Anxiety” of different types is a problem associated with every diagnosis of prostate cancer. Such anxiety comes with particular implications for men implementing active surveillance as an initial management strategy after initial diagnosis with very low-, low-, or favorable intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, anxiety, change, surveillance, time | 2 Comments »
The new PSMA-based PET scans provide a way to locate exactly where the cancer has spread to after an unsuccessful prostatectomy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: change, gallium-68, PET, plan, PSMA, radiation, salvage, scan, Treatment | 6 Comments »
The population-based rate of Medicare patients getting treatment for prostate cancer dropped by 42 percent from 2007 to 2012 … but this drop did not occur in patients who had a high risk of dying from a cause other than prostate cancer within 10 years, who are arguably among those who least need immediate treatment for prostate cancer (and especially for low-risk forms of prostate cancer). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: change, Diagnosis, Management, Medicare, risk, Treatment | 1 Comment »
The practical value of any type of diagnostic and prognostic technology can only really be assessed in the context of whether the data generated by that technology change the way that physicians treat (or make recommendations about treatment for) individual patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: change, PET, PET/CT, scan, Treatment | 2 Comments »
A new report based on data from the cohort of patients being managed with active surveillance (AS) at the University of California, San Francisco, has emphasized the potential importance of repeat biopsies in the care and treatment of these men. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, biopsy, change, PSA | 2 Comments »
It is common for patients to suggest that primary care physicians should be more knowledgeable about the appropriate use of PSA testing and about how to interpret the results of such tests. However, changing physician behavior is not an easy or a quick process, as the following article will demonstrate. … READ MORE …
Filed under: Diagnosis | Tagged: behavior, change, education, physician, PSA | 10 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 